Bayesian Enrichment Strategies for Randomized Discontinuation Trials

DOI10.1111/j.1541-0420.2011.01623.xzbMath1241.62169OpenAlexW2070311219WikidataQ36886980 ScholiaQ36886980MaRDI QIDQ2894009

Peter Mueller, Lorenzo Trippa, Gary L. Rosner

Publication date: 27 June 2012

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3667626

zbMATH Keywords

clinical trialstumor growth modelsenrichment designsrandomized discontinuation design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian problems; characterization of Bayes procedures (62C10) Medical applications (general) (92C50)

Related Items

Robust meta‐analytic‐predictive priors in clinical trials with historical control information ⋮ Bayesian designs and the control of frequentist characteristics: A practical solution ⋮ Random norming AIDS analysis of non-linear regression models with sequential informative dose selection ⋮ Randomized discontinuation trials with binary outcomes ⋮ Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design

Cites Work

• A new stochastic Gompertz diffusion process with threshold parameter: computational aspects and applications
• Optimal Design via Curve Fitting of Monte Carlo Experiments
• Optimal Statistical Decisions
• Bayes estimation of reliability for the two-parameter lognormal distribution
• Parameter Estimation in a Gompertzian Stochastic Model for Tumor Growth
• Stochastic Dominance among Log-Normal Prospects
• Statistical Methods for Eliciting Probability Distributions